×

Stocks SAP AG

  • Close-up of a pen on stock price chart

    SAP shares rose on Wednesday after the company posted strong earnings and raised its outlook, despite market fears over the debt situation in Europe and the US.

  • stock_ticker_blur_200.jpg

    European stocks were indicated to open slightly lower on Wednesday as investors kept a close eye on attempts to get agreement on the US debt ceiling and ahead of a raft of corporate earnings.

  • Investors should buy dips in solid corporate stocks with strong balance sheets rather than look for value in the volatile banking, sector for which the outlook remains very uncertain, Chris Tinker, co-founder of Libra Investment Services, told CNBC on Monday.

  • In the current difficult market, investors should "have faith" in large-cap value stocks, Templeton Global Balanced Fund portfolio manager Lisa Myers told CNBC Wednesday.

  • Facebook

    What would Facebook look like without photos of drunken nights out and tales of misbehaving cats? It might look a lot like the internal social network at the offices of Nikon Instruments.

  • NN_c_suite_200.jpg

    It's the latest catch phrase to grab a hold of Silicon Valley, "Big Data". The size of data sets is getting so large that its getting harder for companies and firms to handle, analyze and securitize the tremendous amount information that is coming in.

  • Austria

    Talk about a possible default by Greece has caused some concern for SAP in Central and Eastern Europe but it is not changing the company's plans, Manfred Joseph, managing director at SAP CEE, told CNBC.com.

  • Stocks ended higher for the day on optimism over prospects of a Greek bailout package, despite several reports of economic weakness, but the gains weren't enough to erase a month of losses.

  • Stocks added to gains reached on optimism over prospects of a Greek bailout package, despite several reports of economic weakness, but the gains weren't enough to erase a month of losses.

  • SAP Headquarters

    SAP’s Co-CEO told CNBC on Monday that the company is aiming to be worth 20 billion euros ($28 billion) by 2015.

  • What's Next?

    The headwinds facing the global economy, while significant, have yet to impact stock markets as investors have focused on rising profitability and the "risk-on" trade being underpinned by loose monetary policy.

  • Ben Bernanke

    The outcome of Wednesday's first ever Federal Open Market Committee (FOMC) press conference is likely to set the tone for the week's and potentially the quarter's trade, with the point at which investors can confirm the end or extension of quantitative easing by the US central bank fast approaching.

  • His day job is running SAP, the German technology giant that battles for supremacy with Oracle in the business software market across the world, so when Bill McDermott speaks, it is worth paying attention.

  • Oracle's headquarters in California.

    The business software giant reported a profit that surpassed Wall Street's forecasts by four cents a share, and the company increased its quarterly dividend.

  • With the debut of public offerings from Demand Media and Nielsen already this year, analysts expect the tech industry to see a large number of new issuances in 2011.

  • Many traders are awaiting results from Cisco Systems after the bell today (Wednesday), but it was rival Juniper Networks that turned heads yesterday in the option market.

  • It's not quite the 'Strange Case of Dr. Jeckyll and Mr. Hyde' but it's close. With so many nations in Europe too scary for investors, would you believe one is actually attractive?

  • Two of the nation’s most important tech giants reported earnings after the bell. What must you know before you place your next bet?

  • Stocks bounced off the lows of the session but ended lower as disappointing economic news halted the market's rally and as Merck dragged down the Dow amid problems with a key blood-clotting drug. Merck and Alcoa slumped, as Home Depot rose.

  • Stocks slumped more in the final hour of trading as disappointing economic news halted the market's rally and a disappointing drug trial for Merck dragged down the Dow. Merck and Alcoa fell, while Home Depot rose.